Roche Holding Ltd. (VTX:ROG) has been given a consensus rating of “Hold” by the sixteen brokerages that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is CHF 263.
Several equities analysts have recently issued reports on the company. Goldman Sachs Group, Inc. (The) set a CHF 335 price target on Roche Holding and gave the stock a “buy” rating in a research report on Thursday, August 24th. J P Morgan Chase & Co reiterated a “buy” rating and issued a price objective on shares of Roche Holding in a report on Monday, October 16th. Baader Bank set a CHF 231 price objective on Roche Holding and gave the stock a “neutral” rating in a report on Thursday, October 19th. Kepler Capital Markets set a CHF 230 price objective on Roche Holding and gave the stock a “neutral” rating in a report on Monday, September 11th. Finally, Sanford C. Bernstein set a CHF 284 price objective on Roche Holding and gave the stock a “buy” rating in a report on Thursday, July 27th.
ILLEGAL ACTIVITY NOTICE: “Roche Holding Ltd. (ROG) Given Average Recommendation of “Hold” by Analysts” was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://ledgergazette.com/2017/11/13/roche-holding-ltd-rog-given-average-recommendation-of-hold-by-analysts.html.
Roche Holding (ROG) opened at CHF 229.30 on Monday. Roche Holding has a 1 year low of CHF 218.30 and a 1 year high of CHF 273.
About Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.